onlyTrustedInfo.comonlyTrustedInfo.comonlyTrustedInfo.com
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Reading: Circle stock downgraded to Sell by Wall Street analyst citing rising competition, valuation concerns
Share
onlyTrustedInfo.comonlyTrustedInfo.com
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Search
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
  • Advertise
  • Advertise
© 2025 OnlyTrustedInfo.com . All Rights Reserved.
Finance

Circle stock downgraded to Sell by Wall Street analyst citing rising competition, valuation concerns

Last updated: July 22, 2025 1:56 pm
OnlyTrustedInfo.com
Share
4 Min Read
Circle stock downgraded to Sell by Wall Street analyst citing rising competition, valuation concerns
SHARE

Circle (CRCL) stock fell as much as 8% Tuesday after getting hit with a downgrade from Compass Point analysts who said the stock may be overvalued as competition in the space heats up.

The firm downgraded Circle to Sell from Neutral and lowered the stock’s price target to $130 from $205.

The development comes on the heels of the Genius Act signed into law by President Trump last week. The legislation, designed to regulate the issuance and oversight of digital tokens backed by assets such as the US dollar and short term Treasury bills, has been a major catalyst for Circle stock. Shares are up more than 500% since the company’s blockbuster IPO on June 5.

“While we expected CRCL to rally into stablecoin legislation, crypto investors typically ‘sell the news’ after highly anticipated events,” crypto and equity research analyst Ed Engel said in a note on Monday.

“As such, we expect CRCL to retrace some of its recent rally,” he added.

Circle makes much of its money from interest income — specifically from short-term Treasury bills backing its stablecoin, USDC (USDC-USD).

In recent weeks, Wall Street analysts have flagged risks heading into the back half of the year for the highflier, including rising distribution costs given that a significant portion of its reserve income is shared with partners like Coinbase (COIN).

“In the coming months, we expect Circle to expand its distribution network while sharing a greater percent of interest income,” Engel wrote.

“We also expect traditional banks and Fintechs to announce competing stablecoin products,” he added.

Earlier this month, Mizuho analyst Dan Dolev initiated coverage of the stock with an Underperform rating and a $85 price target. He noted that if the Federal Reserve starts cutting interest rates in September, yields on Treasurys would decline, impacting Circle’s bottom line.

Read more: How the Fed rate decision affects your bank accounts, loans, credit cards, and investments

“We believe consensus does not fully account for looming interest rate cuts, and also overstates USDC’s medium-term growth potential,” wrote Dolev and his team.

Not everyone is bearish on the stock. Wall Street remains divided, with nine Buy, six Hold, and four Sell ratings, according to Bloomberg data.

Last Friday, Seaport Research Partners raised its price target on Circle to $280 from $235.

“For CRCL, we see the Genius Act passing as a watershed moment that will eventually unlock a substantial amount of new opportunity for stablecoins,” analyst Jeff Cantwell wrote.

“CRCL is a global leader in stablecoins and is the purest stablecoin play in the public markets right now, and we anticipate further gains in the shares as the company creates new opportunities for itself and its partners,” he added.

Ines Ferre is a senior business reporter for Yahoo Finance. Follow her on X at @ines_ferre.

Click here for in-depth analysis of the latest stock market news and events moving stock prices

Read the latest financial and business news from Yahoo Finance

You Might Also Like

Analysis-Ferrero poised to revive WK Kellogg sales for health-conscious Americans

8 Most Expensive Restaurants in the World

Jensen Huang says all companies will have a secondary ‘AI factory’ in the future

10 Most Livable Towns Where Your Single-Income Paycheck Goes Furthest

Amgen gears up for phase 3 trial of monthly weight-loss drug MariTide amid mixed investor sentiment

Share This Article
Facebook X Copy Link Print
Share
Previous Article Breakthrough discovery links Neanderthal DNA and autism Breakthrough discovery links Neanderthal DNA and autism
Next Article Trump announces trade deal with Japan that lowers threatened tariff to 15% Trump announces trade deal with Japan that lowers threatened tariff to 15%

Latest News

PFL Brussels 2026: Why the Odds Are Stacked Against the Underdogs in a Night of Dominant Favorites
PFL Brussels 2026: Why the Odds Are Stacked Against the Underdogs in a Night of Dominant Favorites
Sports May 23, 2026
Ja Morant Spotted at WNBA’s Dream vs. Wings: What His Presence Means for the NBA Star and Women’s Basketball
Ja Morant Spotted at WNBA’s Dream vs. Wings: What His Presence Means for the NBA Star and Women’s Basketball
Sports May 23, 2026
WWE Clash in Italy: Rhea Ripley vs. Jade Cargill Rematch Confirmed—Why This Title Showdown Matters
WWE Clash in Italy: Rhea Ripley vs. Jade Cargill Rematch Confirmed—Why This Title Showdown Matters
Sports May 23, 2026
Gerrit Cole’s Triumphant Return: 6 Shutout Innings After 569-Day Absence, But Yankees Fall to Rays
Gerrit Cole’s Triumphant Return: 6 Shutout Innings After 569-Day Absence, But Yankees Fall to Rays
Sports May 23, 2026
//
  • About Us
  • Contact US
  • Privacy Policy
onlyTrustedInfo.comonlyTrustedInfo.com
© 2026 OnlyTrustedInfo.com . All Rights Reserved.